Legislation is headed to President's desk for signature May 19, 2021 - The U.S. Senate has unanimously approved re-authorization of the National Cord Blood Inventory (NCBI) at up to $23 million annually through Fiscal Year 2026. The Senate sponsors of the bipartisan...

Will Lead Business Development Activities After 14 Years as Executive Director of Maryland Stem Cell Research Fund MIAMI, May 18, 2021 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) ("Longeveron" or "Company"), a clinical stage biotechnology company developing...

BOCA RATON, Fla., May 14, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Noble Capital Markets (“Noble”), a research-driven investment bank, today announces its platinum-level sponsorship of, and collaboration with, the 16th World Stem Cell Summit, to be held virtually...

COLUMBIA, Md. (May 10, 2021)—The Maryland Stem Cell Research Commission has approved funding to its second-round of 2021 recipients for a total of $6,052,901. The Commission has also appointed Amritha Jaishankar, Ph.D., the current MSCRF Director - Programs &...

Durham, NC – A study released today in STEM CELLS Translational Medicine offers hope for those suffering from a chronic, difficult to treat condition called non-tuberculous mycobacteria (NTM) lung infection. The study describes how researchers at Case Western...

MIAMI, April 27, 2021 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) ("Longeveron" or "Company"), a clinical stage biotechnology company developing cellular therapies for chronic, aging-related and life-threatening conditions, announces it has been selected to...

ALACHUA, Fla. (PRWEB)April 21, 2021 - Cardiovascular disease kills more than 650,000 Americans annually.(1) Those who survive myocardial infarction remain at risk of death because the human heart has a very limited ability to repair itself. No one has yet found a...

By: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research Link to article The U.S. Food and Drug Administration plays a vital role in facilitating the development and availability of innovative medical products. Products such as...

Durham, NC - A phase 2 clinical trial whose results were released today in STEM CELLS Translational Medicine might point to a way to overcome bronchopulmonary dysplasia (BPD), a major cause of death in preterm infants. The study, conducted by researchers at Samsung...

Durham, NC – A study released today in STEM CELLS Translational Medicine suggests a new way to correct facial atrophy of localized scleroderma (LoS) in patients. It shows how applying grafts made up of the patient’s own fat enhanced with adipose‐derived stem cells...

Diabetes Research Institute Investigators Will Lead the First Site Activated for the Vertex Study MIAMI, FL – April 6, 2021 – Researchers with the Diabetes Research Institute (DRI) at the University of Miami Miller School of Medicine and Vertex Pharmaceuticals...